Nation | by AFP
British pharmaceuticals giant AstraZeneca reported on Friday $275 million (Sh29.6 billion) in sales from its Covid vaccine in the first three months of the year.
It is the first time that the company discloses figures from sales of one of the world’s leading vaccines. AstraZeneca’s Covid-19 jab was developed with the University of Oxford and has been key in Britain’s rapid vaccination drive. The company is selling it at cost price…
